The use of therapeutic apheresis techniques in liver support therapy is essential to eliminate non-soluble toxins from the bloodstream. When used in addition to dialysis procedures that remove soluble pathogens, the patient’s needs can be comprehensively met.
There are two main categories of liver failure: acute and acute-on-chronic. Acute liver failure is a syndrome in which patients without pre-existing liver disease sustain an acute liver injury and rapid loss of hepatic function. In contrast, acute-on-chronic liver failure is defined as an acute deterioration of liver function in patients known to have underlying compensated chronic liver disease or stable, compensated cirrhosis.1